ID: ALA3277271

Max Phase: Preclinical

Molecular Formula: C20H33NO6S

Molecular Weight: 325.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(C)(C)CSCCCNCC(O)COc1ccccc1.O=C(O)C(=O)O

Standard InChI:  InChI=1S/C18H31NO2S.C2H2O4/c1-4-18(2,3)15-22-12-8-11-19-13-16(20)14-21-17-9-6-5-7-10-17;3-1(4)2(5)6/h5-7,9-10,16,19-20H,4,8,11-15H2,1-3H3;(H,3,4)(H,5,6)

Standard InChI Key:  AJXPTMLHTQKYNT-UHFFFAOYSA-N

Associated Targets(non-human)

Felis catus 3858 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 325.52Molecular Weight (Monoisotopic): 325.2076AlogP: 3.58#Rotatable Bonds: 12
Polar Surface Area: 41.49Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.57CX LogP: 3.79CX LogD: 1.66
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.58Np Likeness Score: -0.63

References

1. Tucker H, Coope JF..  (1978)  beta-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols.,  21  (8): [PMID:29123] [10.1021/jm00206a010]

Source